scorecardresearch
Tuesday, August 19, 2025
TopicBiosimilar drugs

Topic: biosimilar drugs

India’s draft guidelines on biosimilar drugs can make treatments more accessible, affordable

Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

On Camera

Why Modi, BJP should worry about bad blood between CEC Gyanesh Kumar and Rahul Gandhi

If there is bad blood between the CEC and the Opposition leaders, it will shake the people’s faith in election results. It’s the worst thing that could happen to Indian democracy.

Navigating Trump’s tariffs is no child’s play. Indian toymakers are losing out on orders, enquiries

Indian toymakers are now exploring new markets, but they want govt to negotiate a trade deal with US soon, introduce incentives and subsidies to make the industry more competitive.

India provides Nepal with military equipment, medical supplies; PM Oli likely to visit next month

New Delhi: India has handed over military equipment, medical supplies, trained dogs and horses to the Nepalese Army Monday, ahead of Prime Minister K.P....

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?